![Frank Weber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Weber
Vorstandsvorsitzender bei
VIVORYON THERAPEUTICS N.V.
Vermögen: 248 417 $ am 31.05.2026
Profil
Dr. Frank T.
Weber, MD, is a CEO, Executive Director & Chief Medical Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV and Zambon Biotech SA. Dr. Weber was previously employed as a Chief Medical & Development Officer by Spexis Ltd., a Senior Vice President-European Medical Division by InterMune International AG, a Medical Director by MedNet GmbH, a Chief Medical Officer by Merck KGaA, and a Chief Medical Officer by Merck Serono SA. He received his doctorate degree from Universität zu Köln.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2026 | 168’950 ( 0.57% ) | 248 417 $ | 31.05.2026 |
Aktive Positionen von Frank Weber
| Unternehmen | Position | Beginn |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Vorstandsvorsitzender | 14.08.2023 |
Ehemalige bekannte Positionen von Frank Weber
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK KGAA | Technik-/Wissenschafts-/F&E-Leiter | - |
InterMune International AG
 InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Corporate Officer/Principal | - |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Technik-/Wissenschafts-/F&E-Leiter | - |
MedNet GmbH
 MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Corporate Officer/Principal | - |
| SPEXIS AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Frank Weber
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
MedNet GmbH
MedNet GmbH Medical DistributorsDistribution Services Wholesales medical devices and semi-finished products | Distribution Services |
InterMune International AG
InterMune International AG Miscellaneous Commercial ServicesCommercial Services Leases nonfinancial intangible assets | Commercial Services |
